Form C BioEclipse Therapeutics,

  
    C
    
      
        
          0001780708
          XXXXXXXX
        
        021-342724
      
      LIVE
      
        false
        true
        false
      
    
  
  
    
      
        BioEclipse Therapeutics, Inc.
        
          Corporation
          DE
          05-26-2006
        
        
          319 North Bernardo Avenue
          Mountain View
          CA
          94043
        
        https://www.bioeclipse.com
      
      N
      NetCapital Funding Portal Inc.
      0001669191
      007-00035
      283596
    
    
      Up to 4.9% of amount raised for a successful offering and a listing fee of up to $5,000
      None.
      Common Stock
      3922
      2.55000
      The price of the Securities was determined solely by Management and bears no relation to traditional measures of valuation such as book value or price-to-earnings rat... [Truncated: see complete discussion in attachment offeringstatement.pdf, question 21.]
      10001.10
      Y
      First-come, first-served basis
      1069997.85
      03-01-2022
    
    
      5
      2956073.00
      5839337.00
      2331499.00
      5394836.00
      0.00
      0.00
      75862.00
      0.00
      0.00
      0.00
      0.00
      0.00
      0.00
      0.00
      0.00
      0.00
      -4391188.00
      -2415736.00
      AL
      AK
      AZ
      AR
      CA
      CO
      CT
      DE
      DC
      FL
      GA
      HI
      ID
      IL
      IN
      IA
      KS
      KY
      LA
      ME
      MD
      MA
      MI
      MN
      MS
      MO
      MT
      NE
      NV
      NH
      NJ
      NM
      NY
      NC
      ND
      OH
      OK
      OR
      PA
      RI
      SC
      SD
      TN
      TX
      UT
      VT
      VA
      WA
      WV
      WI
      WY
      B5
      GU
      1V
      PR
      VI
    
    
      
        BioEclipse Therapeutics, Inc.
        Pamela Contag
        Principal Executive Officer
      
      
        
          Pamela Contag
          Principal Executive Officer
          01-19-2022
        
        
          Pamela Contag
          Principal Financial Officer
          01-19-2022
        
        
          Pamela Contag
          Principal Accounting Officer
          01-19-2022
        
        
          Gregory Schiffman
          Board Member
          01-19-2022
        
        
          Cathy Sohn
          Board Member
          01-19-2022
        
        
          Pamela Contag
          Board Member
          01-19-2022
        
        
          Mark Frohlich
          Board Member
          01-19-2022
        
      
    
  

You May Also Be Interested In

• Keep Up with Kitchen Trends
• BioMedNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A) Announces Celly Nu, Six+One Collaboration to Launch unbuzzd(TM)
• Sedgwick announces retirement of Executive Chairman Dave North